MedRhythms Inc., a Portland-based digital health startup that uses sensors, software and music to help restore nervous system functioning and walking ability, has obtained $25 million in Series B venture capital funding.
The company on Wednesday said it will use the money to expand its team and operations. The financing was co-led by Morningside Ventures and Advantage Capital, with participation from existing investor Werth Family Investment Associates.
MedRhythms has raised a total of $34 million in private financing since launching in 2015. Previous funding included a round with investments from the Maine Venture Fund and the Maine Technology Institute, and Series A financing that raised over $5 million. Read more
